A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...
Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition ...
The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...
In a first-in-human phase 1/2a clinical trial, researchers used adult stem cells to help restore vision in people with age-related macular degeneration. In the United States, age-related macular degen ...
Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has completed the, Inc. (Melt), a clinical-stage pharmaceutical company ...
Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has completed the acquisition ...
2don MSN
Reducing inflammation may protect against early age-related macular degeneration-like vision loss
University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...
In this video, David A. Eichenbaum, MD, FASRS, discusses late-stage wet age-related macular degeneration assets presented at the American Academy of Ophthalmology meeting.Eichenbaum noted that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback